← Back to Clinical Trials
Recruiting NCT06844643

NCT06844643 The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06844643
Status Recruiting
Phase
Sponsor China-Japan Friendship Hospital
Condition Axial Spondyloarthritis
Study Type OBSERVATIONAL
Enrollment 2,250 participants
Start Date 2025-03-01
Primary Completion 2030-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,250 participants in total. It began in 2025-03-01 with a primary completion date of 2030-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18 years or older * Diagnosis of axial spondyloarthritis (axSpA) according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria Exclusion Criteria: * Presence of severe, unstable medical conditions that may interfere with the study assessments, including but not limited to: End-stage renal disease (eGFR \< 30 mL/min/1.73m²) Severe cardiovascular disease Active malignancy or malignancy requiring ongoing treatment * Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures, which, in the opinion of the investigator, may impair the ability to provide informed consent or comply with follow-up visits. * Pregnant or lactating women

Contact & Investigator

Central Contact

weiping kong

✉ kongweiping75@126.com

📞 0086-10-13611038252

Frequently Asked Questions

Who can join the NCT06844643 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Axial Spondyloarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06844643 currently recruiting?

Yes, NCT06844643 is actively recruiting participants. Contact the research team at kongweiping75@126.com for enrollment information.

Where is the NCT06844643 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06844643 clinical trial?

NCT06844643 is sponsored by China-Japan Friendship Hospital. The trial plans to enroll 2,250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology